Orlistat (OLS)

[Edit]

Tetrahydrolipstatin; Xenical; Alli

Orlistat (OLS)
Orlistat is a drug designed to treat obesity.Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet. Orlistat is the saturated derivative of lipstatin, a potent natural inhibitor of pancreatic lipases isolated from the bacterium Streptomyces toxytricini. However, due to its relative simplicity and stability, orlistat was chosen over lipstatin for development as an anti-obesity drug. Orlistat also modestly reduces blood pressure, and appears to prevent the onset of type 2 diabetes, whether due to weight loss itself or to other effects; in a large randomized controlled trial, orlistat was found to reduce the incidence of diabetes by nearly 40% in obese people.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Orlistat (OLS) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Orlistat (OLS) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Orlistat (OLS) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Orlistat (OLS) CLIA Kit Customized Service Offer
n/a ELISA Kit for Orlistat (OLS) ELISA Kit Customized Service Offer